Inventor · disambiguated record
Philip D. Greenberg
Also filed as: GREENBERG PHILIP · GREENBERG PHILIP D
16 granted patents·12 pending applications·879 citations·filing 1994–2024
92Inventor score
Files withFRED HUTCHINSON CANCER CENTER12HUTCHINSON FRED CANCER RES12ADAPTIVE BIOTECHNOLOGIES CORP1AFFINI T THERAPEUTICS INC1UNIV ILLINOIS1
Top patents by PatentIndex Score
28 records- 0197US6040177AHigh efficiency transduction of T lymphocytes using rapid expansion methods ("REM")HUTCHINSON FRED CANCER RES·Filed 1996·Granted Mar 21, 2000·593 cites·24 claims
- 0295US5827642ARapid expansion method ("REM") for in vitro propagation of T lymphocytesHUTCHINSON FRED CANCER RES·Filed 1994·Granted Oct 27, 1998·235 cites·11 claims
- 0388US11725210B2Immunomodulatory fusion proteins and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Aug 15, 2023·4 cites·22 claims
- 0485US11458191B2Binding proteins specific for RAS neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Oct 4, 2022·1 cites·30 claims
- 0585US11041202B2Method of identifying human compatible T cell receptors specific for an antigenic targetADAPTIVE BIOTECHNOLOGIES CORP·Filed 2016·Granted Jun 22, 2021·3 cites·16 claims
- 0684US12012443B2Immunomodulatory fusion proteins and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Jun 18, 2024·1 cites·16 claims
- 0784US11382954B2Binding proteins specific for RAS neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Jul 12, 2022·1 cites·30 claims
- 0882US10538572B2T cell immunotherapy specific for WT-1HUTCHINSON FRED CANCER RES·Filed 2015·Granted Jan 21, 2020·5 cites·47 claims
- 0979US2025109180A1Immunomodulatory fusion proteins and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 1078US2025114433A1Binding proteins specific for ras neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 1176US11026969B2High affinity T cell receptors and uses thereofHUTCHINSON FRED CANCER RES·Filed 2016·Granted Jun 8, 2021·1 cites·17 claims
- 1271US12365906B2Immunomodulatory fusion proteins and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2023·Granted Jul 22, 2025·0 cites·43 claims
- 1371US2023139737A1Binding proteins specific for ras neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 1470US10344075B2Engineered high-affinity human t cell receptorsUNIV ILLINOIS·Filed 2014·Granted Jul 9, 2019·0 cites·13 claims
- 1570US5747292AChimeric cytokine receptors in lymphocytesHUTCHINSON FRED CANCER RES·Filed 1994·Granted May 5, 1998·34 cites·42 claims
- 1664US2025177531A1Binding proteins specific for ras neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 1762US10208086B2Cyclin A1-targeted T-cell immunotherapy for cancerHUTCHINSON FRED CANCER RES·Filed 2012·Granted Feb 19, 2019·1 cites·3 claims
- 1861US2025152717A1Binding proteins and engineered cells specific for neoantigens and uses thereofAFFINI T THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1960US2025250319A1Chimeric transmembrane polypeptides comprising a tgf beta receptor extracellular domain, a transmembrane domain and an interleukin receptor 2 intracellular signalling domain and its use in therapyFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 2059US10875904B2Enhanced affinity T cell receptors and methods for making the sameHUTCHINSON FRED CANCER RES·Filed 2017·Granted Dec 29, 2020·0 cites·33 claims
- 2156US2024209058A1Mesothelin-specific T cell Receptors and Methods of Using SameUNIV MINNESOTA·Filed 2022·Application pending·0 cites
- 2254US2025018036A1Immunotherapy targeting sox2 antigensFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 2351US9751928B2Enhanced affinity T cell receptors and methods for making the sameHUTCHINSON FRED CANCER RES·Filed 2013·Granted Sep 5, 2017·0 cites·20 claims
- 2450US12448430B2High avidity WT1 T cell receptors and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2020·Granted Oct 21, 2025·0 cites·49 claims
- 2550US2022409661A1T-cell immunotherapy specific for wt-1HUTCHINSON FRED CANCER RES·Filed 2020·Application pending·0 cites
- 2646US2018044404A1Immunomodulatory fusion proteins and uses thereofHUTCHINSON FRED CANCER RES·Filed 2016·Application pending·0 cites
- 2743US2019119326A1Cyclin a1-targeted t-cell immunotherapy for cancerHUTCHINSON FRED CANCER RES·Filed 2018·Application pending·0 cites
- 2837US2019127435A1Immunomodulatory il2r fusion proteins and uses thereofHUTCHINSON FRED CANCER RES·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philip D. Greenberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →